Skip to Content

Danish Bladder Cancer Patients Show Similar Outcomes in Clinical Practice and Clinical Trials

Two studies evaluating all Danish patients with bladder cancer treated with first-line chemotherapy and all-line pembrolizumab, respectively, have found similar outcomes and overall survival rates between patients treated in clinical practice and those from clinical trials.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top